ARTICLE | Clinical News
BioSyntech preclinical data
September 23, 2002 7:00 AM UTC
BSYI said that in a mouse model of breast cancer Pacligel implants inhibited tumor growth, which was maintained for 80 days. Pacligel showed no signs of systemic toxicity and loss in body weight, and ...